In order to improve vaccine supply in Africa, BioNTech SE has introduced a new approach to establishing scalable vaccine production by developing and delivering turnkey mRNA manufacturing facilities based on a container solution.   At a high-level meeting at BioNTech’s new manufacturing facility in Marburg and at the invitation of kENUP Foundation, the company presented the container solution named “BioNTainer” to key partners.    Attendees included president Macky Sall of Senegal, president...